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The multi-facetedEmployee health protection is an employer responsibility.
aspects of employee protection from the potentially harmful effects of inorganic lead
sometimes stress the relationships of several employer units. These include supervision
and management, safety, operations and maintenance, engineering, environmental health,
environmental management, and occupational medicine.
The administrative aspects of program development are going to be discussed.
My presentation today is to emphasize the opportunity for cooperation by all of the
employee health components in developing an optimum surveillance and protection
program.
References to biological monitoring may be confusing. I would like to try to
clarify some of the terminology.
Clinical Monitorin2 refers to the physical examination which includes the review
of the history and the hands-on examination.
Medical Monitorin2 is sometimes called "health effects monitoring" and is the
standardized assessment of measurable biological functions which is a part of most
comprehensive physical examinations. This would include the standard blood
chemistry monitoring for liver, metabolic, kidney, and musculoskeletal
abnormalities, as well as such tests as the electrocardiogram and pulmonary
function. These are compared to a population normal as well as to the individual's
baseline values.
Biological Monitorin2 is sometimes called "biochemical effects monitoring" and
is the evaluation of specific environmental exposures through measurements of the
agent or its metabolites in biological samples. These results are compared to
reference values known as biological exposure indices (BEI).
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Environmental Monitoring is the evaluation of exposure by sampling of the
workplace environment for known or suspected hazardous agents. These results
are compared to the published threshold limit values (TLV or PEL).
Much of the concern in the workplace is related to increasing public awareness
regarding lead as a public health hazard. There is a general recognition that as many as
4 million children in the United States are at increased risk of lead poisoning, and that
children have a greater sensitivity to the harmful effects of lead than do adults. The
incomplete development of the blood-brain barrier in the very young child increases the
risk of lead entry into the developing nervous system until around 3 years of age. This
can result in prolonged neuro-behavioral problems. Children absorb and retain more lead
in proportion to their weight. Iron deficiency, a condition more likely to occur in young
children, increases the absorption of lead from the gastrointestinal (G.I.) tract. Since
lead freely crosses the placenta, the fetus is at greatest risk. In fact, it is uncertain just
how low maternal blood lead should be to avoid any threat to the developing fetus.
There is increasing evidence of some developmental effect on the nervous system in
infancy or perhaps in utero of blood lead levels even below 15 microgram per deciliter
(mcg/dl). Several studies of non-occupationally exposed adults have shown that blood
lead levels of 20 Mg/dl is not unusual. The average blood lead level in the United States
population is stated to be about 10 mcg/dl before the legislated removal of lead from
gasoline which began in 1976. Even the 10 mcg/dl population average is about three
times higher than the average level found in some remote populations, and may be as
much as 30 times higher than the theoretical level calculated for pre-industrial humans.
Until recently, population screening was often done by testing for erythrocyte
protoporphyrin, commonly assayed as zinc protoporphyrin (ZPP). Lead inhibits the
ferrochelase enzyme, which results in iron being unable to be incorporated into the
protoporphyrin ring. Zinc has a greater affinity for protoporphyrin than iron in the
absence of ferrochelase and, hence, increased amounts of ZPP are formed. This ZPP
reaches a steady state in the blood only after the entire population of circulating red
blood cells has turned over. This takes about 120 days; hence, the ZPP level lags behind
the blood lead level and is an indirect measure of long-term lead exposure. A
disadvantage of ZPP screening is that it is not sufficiently sensitive at the lower levels
of lead exposure. Data from the Second National Health and Nutritional Examination
Survey indicated that 58 percent of 118 children with blood lead levels above 30 mcg/dl
had ZPP levels within normal limits. While ZPP level is still useful, it is not considered
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asgooda screeningtestastheblood lead. Thenormal levels for ZPPare usuallybelow
35 mcg/dl. Therearediseaseswhich maycausea falsely elevatedlevel, so the results
shouldbe interpretedwith clinical correlationandknowledgeof the blood leadlevel.
Florida requiresthe reporting of children's blood lead levels of 15 mcg/dl or
higher. In 1989,28 statesand the District of Columbiarequiredreporting blood lead
levels in children. Seventeenof thesestatesrequiredreportingblood leadlevels of 25
mcg/dl or higher.
In 1991,theU.S. Departmentof HealthandHumanServicesreleaseda strategic
plan for the eliminationof childhoodleadpoisoningas a public healthproblemover a
20-year effort. During 1992, there was funding for an effort to build a national
surveillancesystemfor monitoringchildren's blood lead.
While weall recall thestoriesof theinter-city leadpoisoningepidemicin toddlers
whentheyteethedon thewindow facingsof woodpaintedwith leadpaint, therewasthe
notion thatby restrictingtheleadcontentof paints,which occurredin 1977,theproblem
would be eliminated. There are, however, a number of other sources of lead exposure
in children, not the least of which is lead that may be brought home on the garments and
tools of parents from the workplace.
We also have a greater recognition of the potential for adverse reproductive
effects in both males and females. These findings have influenced the development of
lead standards with regard to surveillance recommendations.
There are more than one hundred different occupations in which workers may be
exposed to lead. Some of these are shown in Exhibit 1. Not only may lead dust and
lead oxide fumes be inhaled, but lead particulates may be ingested in food, beverage, and
smoke. If a proper shower and clothing change is not provided, it is possible to bring
lead home on the skin, shoes, and clothing, and inadvertently expose family members.
When inorganic lead enters the body, it is not metabolized but is directly absorbed,
distributed, and excreted. Inhaled lead is completely absorbed from the lower respiratory
tract. Only about 10 or 15 percent of the lead ingested in the G.I. tract is absorbed, but
this amount increases to as much as 50 percent in children and pregnant women and, if
iron or calcium deficiency or fasting nutritional problems exist, then even greater
quantities may be absorbed.
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Exhibit 1. Some Sources of Lead Exposure
Auto Repairs
Battery Workers
Construction Workers
Gas Station Attendants
Glass Manufacturing
Lead Miners
Pipe Fitters
Plumbers
Policemen
Printers
Reconstruction Workers
Ship Builders
Smelters and Refiners
Once in the body, lead is distributed mainly in three compartments: the blood;
soft tissues which include kidney, bone marrow, liver, and brain; and mineralizing
tissues which are bones and teeth. About 95 percent of the total body burden of lead in
adults is contained in the bones and teeth. About 99 percent of the lead in the blood is
associated with the red blood cells (erythrocytes). The remaining 1 percent is in the
plasma, where it is available for transport to other tissues. If the lead in the blood is not
retained, it is excreted through the kidneys or through biliary clearance into the G.I.
tract. The half-life of lead in blood is about 25 days, in soft tissues about 40 days, and
in non-labile bone more than 25 years. After a single exposure, a person's blood level
may begin to return to normal, but the total body burden will stay elevated. Since the
body accumulates lead over a lifetime and releases it slowly, even small doses over time
may cause harm. A major one-time exposure to lead is not necessary for serious lead
poisoning.
We have been doing lead determinations at the Kennedy Space Center (KSC) for
several years and, as shown in Exhibit 2, the numbers have significantly increased since
1986.
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Exhibit 2. Number of Employees in Surveillance Program
Year Number
1986 1
1987 4
1988 6
1989 6
1990 48
1991 60
1992 255 (to 11/10/92)
We looked at our 1992 data in mid-August and found that there had been 171
blood lead tests requested on workers. The average blood lead was less than 5 mcg/dl,
with a range from 0 to 24 mcg/dl. With such a low average in a workforce presumed
to have been tested because of some workplace exposure, we felt that we needed to more
closely confirm that we were monitoring the right worker group. There has been in
place for several years a close communication between the two divisions of our
department. When a lead worker's physical examination was requested, the name of the
worker, his employer, and the worksite information was sent to our Environmental
Health Division for confirmation that:
. This workplace had previously been identified as a possible lead
exposure environment.
. This worker had been identified as an employee in that environment
and that environmental data had been obtained to confirm that there
was a need to have this person entered into the Lead Surveillance
Program.
Likewise, when requests were made to the Environmental Health Division for
investigation or surveillance of a possible lead environment, that information was
communicated to the Occupational Medicine Division along with a list of employees who
were identified to be placed in the Lead Medical Surveillance Program. The concern
intensified within EG&G because of the identification of new work in lead/paint removal
and lead abatement projects.
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The surveillanceprogramat theKennedySpaceCenterhasshownseveralareas
where leadexposureis abovethepermissibleexposurelevel. Theseare sandblastingof
leadedpaint in semi-enclosedor enclosedareas,welding, andgrinding of lead-painted
surfaces in enclosed or semi-enclosedareas, cable splicing of lead sleevesinside
manholesor under canvasenclosures,andtargetpracticeonpartially enclosedoutdoor
ranges. Numerousotheroperationshaveidentifiedleadin theenvironment,but at levels
below thepermissibleexposurelevel.
Theeffort to get all possiblyexposedworkersinto thesurveillanceprogram has
brought the number to 255 workers throughNovember10, 1992. The resultsof the
biomonitoring are shownin Exhibit 3.
Exhibit 3
1/1/92 to 11/11/92
255 Employees in Surveillance Program
Average Blood Lead 4.59 mcg/dl (0-24)
Average ZPP 20.38 mcg/dl (9-61)
In addition, 21 employees alleging possible exposure but who do not work in a
lead environment have been evaluated. Those results are shown in Exhibit 4.
Exhibit 4. Testing of "Non-Lead" Workers
21 Employees
Average Blood Lead 3.43 mcg/dl (0-13)
Average ZPP 15.76 mcg/dl (10-52)
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While we have no specific explanation for the fact that our worker blood lead
levels are so low in our surveillance program, we generally attribute this to a
combination of factors. The most important is probably that this particular area of
Florida has very low natural exposure to environmental leads from drinking water,
automobile emissions, etc.; that many of the buildings and rapid growth in the
communities have occurred since the mid-1970's; and that our worker protection
programs at the Space Center have been effective. We have looked closely at the
laboratory where our blood lead and ZPP levels are determined. The same lab has been
used for nine years. It has all of the appropriate certifications, and we are confident in
the accuracy of the results.
Because of the low levels in our employees, we have suggested that in our
Hazardous Paint Removal Program and Lead Medical Surveillance Program we use 25
mcgs/dl as the action level.
Our program has been written to indicate that employees will be notified of actual
blood lead level if their blood lead exceeds 25 mcgs/dl, and the Environmental Health
Division will be notified in order to evaluate the employees' work practices and other
non-work sources of possible exposure. A medical examination and consultation will be
performed on any employee found to have a blood lead exceeding this action level. It
should be noted that the Occupational Safety and Health Administration (OSHA) Lead
Standard recommends 40 mcgs/dl as the action level. We have also proposed that the
medical removal level be established at 40 mcgs/dl (60 mcgs/dl in the OSHA Lead
Standard), and that employees be considered for removal from exposure when their blood
lead is above this level. Each case will be evaluated by the Medical Director or Deputy
Medical Director to determine if the employee is at increased risk of material impairment
to health from exposure to lead prior to a determination with regard to either removal
or return to employment in a lead environment exceeding the action level.
We believe that this very conservative approach is justified by our knowledge of
the low blood lead levels in our workforce, but an individual decision would be made on
each employee with the recognition that our job not only is to protect the health of the
employee, but also to assure that every employee can continue to work safely.
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